Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Donepezil for Refractory Diabetic Wound Healing
NCT04505670Phase 2Unknown
- Sponsor
- University of Maryland, Baltimore
- Start
- Aug 2020
- Primary completion
- Jul 2023
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 2, randomised, double-blind trial of donepezil in diabetic foot ulcer (DFU), sponsored by University of Maryland, Baltimore. Primary endpoint: Change in depth wound at 4 weeks. Status: unknown.
02
Drugs
donepezil
03
Conditions
diabetic foot ulcer (DFU)
Beyond the preview
Go deeper on NCT04505670.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT04505670.